NCT06915870 - Comparison of Empagliflozin and Dapagliflozin in Patients With Heart Failure Taking Standard Treatment | Biotech Hunter

Enrollment

108

Participants

Timeline

Start Date

July 12, 2024

Primary Completion Date

January 13, 2025

Study Completion Date

January 13, 2025

Conditions

Diabetes MellitusHeart Failure

Interventions

DRUG

Dapagliflozin 10 mg daily

Dapagliflozin 10 mg daily for 12 weeks. Standard SGLT2 and ARNI treatment was given as per standard protocol. All patients were followed-up in OPD after 12 weeks for assessment of ejection fraction by using echocardiography

DRUG

Empagliflozin 10 MG OD

Empagliflozin 10 mg daily for 12 weeks. Standard SGLT2 and ARNI treatment was given as per standard protocol. All patients were followed-up in OPD after 12 weeks for assessment of ejection fraction by using echocardiography

Trial Locations (1)

54600

Shaikh Zayed Hospital, Lahore

All Listed Sponsors

lead

Fatima Maqsood

OTHER_GOV